![](/img/cover-not-exists.png)
Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab
Pang, Juntao, Xing, Huaixin, Sun, Yingui, Feng, Shuo, Wang, SuzhenVolume:
125
Language:
english
Journal:
Biomedicine & Pharmacotherapy
DOI:
10.1016/j.biopha.2020.109861
Date:
May, 2020
File:
PDF, 5.11 MB
english, 2020